Covid disrupted HIV care in Asia-Pacific, 46% dip in frequency of taking tests, survey finds
More than one in three among those who are at risk of contracting HIV have reported they had either decreased or stopped taking HIV preventive medicine, a survey has found.
According to a pulse survey conducted by Kantar Health, funded by biopharmaceutical company Gilead Sciences with guidance and support from the AIDS Society of India, about 50 per cent of prescribers also reported a decline in prescribing refill antiretroviral medication (ART) to Persons Living with Human Immunodeficiency Virus (PLHIV). Read more here
Covid fear looms